Cargando…

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma

Detalles Bibliográficos
Autores principales:	Lopez-Muñoz, N., Hernández-Ibarburu, G., Alonso, R., Sanchez-Pina, J. M., Ayala, R., Calbacho, M., Cuellar, C., Cedena, M. T., Jiménez-Ubieto, A., Iñiguez, R., Pedrera, M., Cruz, J., Meloni, L., Pérez-Rey, D., Serrano, P., de la Cruz, J., Martinez-Lopez, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369832/ https://www.ncbi.nlm.nih.gov/pubmed/37491311 http://dx.doi.org/10.1186/s13045-023-01484-8

Ejemplares similares

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
por: Lopez-Muñoz, N., et al.
Publicado: (2023)

P928: REAL-LIFE ANALYSIS OF THE MULTIPLE MYELOMA PATIENT’S SURVIVAL IN A LARGE COHORT OF PATIENTS
por: Lopez-Muñoz, N., et al.
Publicado: (2022)

Impact of COVID-19 in patients with multiple myeloma based on a global data network
por: Martinez-Lopez, J., et al.
Publicado: (2021)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
por: Muñoz, Maria Nieves Lopez, et al.
Publicado: (2023)

Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
por: Zamanillo, Irene, et al.
Publicado: (2023)

Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
por: Sanz, A., et al.
Publicado: (2022)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)
por: Alegre, Adrián, et al.
Publicado: (2022)

The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements
por: Cedena, Maria-Teresa, et al.
Publicado: (2020)

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
por: Poza, María, et al.
Publicado: (2021)

PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
por: Zamanillo, I., et al.
Publicado: (2022)

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
por: Martinez-Lopez, J, et al.
Publicado: (2017)

P1284: LIQUID BIOPSY BY ULTRA-DEEP SEQUENCING PLUS PET-TC MONITORING IN REAL-LIFE FOLLICULAR LYMPHOMA PATIENTS
por: Jiménez-Ubieto, A., et al.
Publicado: (2022)

P845: IDENTIFICATION OF MULTIPLE MYELOMA BIOMARKERS VIA LIQUID BIOPSY BASED ON CELL-FREE DNA USING A CAPTURE-HYBRIDIZATION PANEL
por: Buenache Cuenda, N., et al.
Publicado: (2022)

P702: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) FOR MINIMAL RESIDUAL DISEASE (MRD) AND CHIMERISM MONITORING IN MYELODYSPLASTIC SYNDROME (MDS) AFTER ALLOGENIC STEM CELL TRANSPLANTATION (ASCT)
por: Zamanillo, Irene, et al.
Publicado: (2023)

P1132: PET INTERIM RESULTS PREDICT PROGRESSION-FREE-SURVIVAL IN FOLLICULAR LYMPHOMA PATIENTS WITH ADVANCED STAGE
por: Poza, M., et al.
Publicado: (2022)

Impact of IPSS-M implementation in real-life clinical practice
por: Zamanillo, Irene, et al.
Publicado: (2023)

P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY
por: Garcia-Vicente, R., et al.
Publicado: (2022)

PB1781: THE APPLICATION OF CF-DNA FOR NGS MRD STUDIES IN PATIENTS WITH LMA IMPROVES THE SENSITIVITY OF THE METHOD WITH RESPECT TO CTC.
por: Sánchez-Redondo, Noemí Álvarez, et al.
Publicado: (2023)

Cytogenetics Findings in a Histiocytic Sarcoma Case
por: Alonso-Dominguez, J. M., et al.
Publicado: (2012)

Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients
por: Ayala, Rosa, et al.
Publicado: (2011)

Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients
por: Espiño, M, et al.
Publicado: (2017)

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
por: Jiménez-Ubieto, Ana, et al.
Publicado: (2023)

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
por: Jiménez-Ubieto, Ana, et al.
Publicado: (2023)

Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma
por: Martinez-Lopez, Joaquin, et al.
Publicado: (2021)

Hormonal Relationships to Bone Mass in Elderly Spanish Men as Influenced by Dietary Calcium and Vitamin D
por: Moran, Jose M., et al.
Publicado: (2013)

Adherence to a Mediterranean Diet and Bone Mineral Density in Spanish Premenopausal Women
por: Pérez-Rey, Jesús, et al.
Publicado: (2019)

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
por: Encinas, Jessica, et al.
Publicado: (2023)

Evaluation of some etiological factors predisposing to diarrhoea in lambs in “La Serena” (Southwest Spain)
por: Andrés, S., et al.
Publicado: (2007)

Relationship between the treatment and the evolution of the clinical course in scouring Merino lambs from “La Serena” (Southwest Spain)
por: Gómez, L., et al.
Publicado: (2008)

Obtaining EHR-derived datasets for COVID-19 research within a short time: a flexible methodology based on Detailed Clinical Models
por: Pedrera-Jiménez, Miguel, et al.
Publicado: (2021)

Measurable residual disease in multiple myeloma: ready for clinical practice?
por: Burgos, Leire, et al.
Publicado: (2020)

Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine
por: Garg, Amit, et al.
Publicado: (2016)

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Alonso Alonso, R., et al.
Publicado: (2022)

TransformEHRs: a flexible methodology for building transparent ETL processes for EHR reuse
por: Pedrera-Jiménez, Miguel, et al.
Publicado: (2022)

P1100: PET INTERIM RESULTS COULD PROMPTLY SELECT FOLLICULAR LYMPHOMA PATIENTS IN NEED OF MAINTENANCE THERAPY. POTENTIAL ADDITIONAL VALUE OF CFDNA.
por: Poza, Maria, et al.
Publicado: (2023)

Influence of Culture Media on Biofilm Formation by Candida Species and Response of Sessile Cells to Antifungals and Oxidative Stress
por: Serrano-Fujarte, Isela, et al.
Publicado: (2015)

Usage Record Format Recommendation
por: Nilsen, J.K., et al.
Publicado: (2013)

Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database
por: McCurdy, Arleigh, et al.
Publicado: (2022)

P869: PRODUCTION BY GUT MICROBIOTA AS PROGNOSTIC BIOMARKER IN MM
por: Rodríguez-García, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4jqlu0rgvqpse3l0lp9snhmagj